Press releases
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
As of last trade Hologic Inc (HO1:HAN) traded at 71.50, -9.17% below its 52-week high of 78.72, set on May 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 71.50 |
---|---|
High | 71.50 |
Low | 71.50 |
Bid | 71.50 |
Offer | 72.00 |
Previous close | 70.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 234.73m |
Free float | 232.98m |
P/E (TTM) | 36.24 |
Market cap | 17.89bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 07:00 BST.
More ▼